The Department of Health and Human Services (HHS) has announced the reactivation of a long-standing task force focused on the safety of childhood vaccinations. This move comes in response to pressure from anti-vaccine groups linked to Robert F. Kennedy Jr.
In a statement released on Thursday, HHS outlined that the task force will concentrate on the development and promotion of pediatric vaccines, emphasizing that these newer vaccines intend to produce fewer side effects compared to existing options.
The task force’s mandate also includes support for reporting side effects and conducting research into vaccine safety.
This initiative traces its origins back to the National Childhood Vaccine Injury Act of 1986, which mandated that the HHS Secretary submit progress reports to Congress every two years.
Comprising senior officials from various federal health agencies, including the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), the task force will be chaired by NIH Director Jay Bhattacharya.
“By reinstating this task force, we are reaffirming our commitment to rigorous science, ongoing improvement, and building trust with American families,” Bhattacharya stated. “The NIH is proud to support this initiative, which aims to enhance vaccine safety and protect children effectively.”
Traditionally, vaccine safety oversight has been the responsibility of the CDC and FDA, with the NIH not having a direct role prior to this.
Critics argue that reviving this task force—and particularly the report presented during the 1998 Congress—could undermine public confidence in vaccines and divert attention from investments in pediatric vaccines.
For years, Kennedy has raised concerns about the safety of childhood vaccines, frequently questioning the long-established measles, mumps, and rubella vaccines, all of which have a solid track record of safety.
Dorit Rice, a law professor at the University of California, San Francisco, commented via email: “Secretary Kennedy’s efforts over the last two decades appear aimed at undermining vaccine confidence, and this could serve as another means to increase accessibility to his claims.”
Kennedy and his allies have shown a long-standing interest in this task force. Its absence, they argue, reflects a lack of governmental action to guarantee child safety regarding vaccines.
The Children’s Health Defense (CHD), an anti-vaccine group established prior to Kennedy’s appointment, supported a lawsuit in May that compelled Kennedy to reestablish the task force and its Congressional reporting.
In 2018, Kennedy, along with vaccine critic Del Bigtree, submitted a Freedom of Information Act request to obtain reports from HHS. When no reports surfaced, they positioned themselves as part of an effort to fortify misleading narratives regarding vaccine safety.
Kennedy has persistently advocated for research into childhood vaccinations. The revival of this safety panel could play a significant role in altering the vaccination schedule for children.
In June, Kennedy dismissed the members of the influential CDC Vaccine Advisory Panel, replacing them with carefully selected individuals, many of whom have expressed doubts about vaccines, including those related to Covid-19.
During the panel’s first meeting weeks later, they revealed plans to investigate the overall effectiveness of childhood and adolescent vaccine schedules.
Earlier this year, Kennedy also mentioned that the Presidential Maha Commission is reviewing the childhood vaccine schedule as a possible factor in the nation’s chronic disease issues.
